Process analytics for purification of monoclonal antibodies.

The application of appropriate analytical methods is an essential requirement for the purification of therapeutic antibodies. A range of analytical methods need to be employed to effectively determine the purity, identity, integrity and activity of these important class of pharmaceuticals. These include notably electrophoresis, high performance liquid chromatography and immunoassays. Regulatory and industry demands in recent years have brought the need for improvements and many have been successfully implemented. This article reviews the current analytical methods applied to support the purification of monoclonal antibodies.

[1]  D E Wierenga,et al.  Administration of tumor cell chromatin to immunosuppressed and non-immunosuppressed non-human primates. , 1995, Biologicals : journal of the International Association of Biological Standardization.

[2]  E. Sheldon,et al.  Picogram quantitation of total DNA using DNA-binding proteins in a silicon sensor-based system. , 1990, Analytical biochemistry.

[3]  M. Waselus,et al.  Element of a validation method for MU‐B3 monoclonal antibody using an imaging capillary isoelectric focusing system , 2002, Electrophoresis.

[4]  Fred Jacobson,et al.  Protein aggregation and bioprocessing , 2006, The AAPS Journal.

[5]  W. Friess,et al.  A Critical Evaluation of Tm(FTIR) Measurements of High-Concentration IgG1 Antibody Formulations as a Formulation Development Tool , 2006, Pharmaceutical Research.

[6]  J. Pelton,et al.  Spectroscopic methods for analysis of protein secondary structure. , 2000, Analytical biochemistry.

[7]  F. Brown,et al.  WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals (Requirements for biological substances N°50) : Safety of Biological Products Prepared from Mammalian Cell Culture , 1998 .

[8]  L C Eaton,et al.  Host cell contaminant protein assay development for recombinant biopharmaceuticals. , 1995, Journal of chromatography. A.

[9]  George M. Hilliard,et al.  Validation of a peptide mapping method for a therapeutic monoclonal antibody: what could we possibly learn about a method we have run 100 times? , 2000, Journal of pharmaceutical and biomedical analysis.

[10]  A. Hartl,et al.  Improvement of antisera raised against complex antigen mixtures by the use of heterologous sources of antigen for immunization. , 1993, Journal of immunological methods.

[11]  M. Eby.  The Reality of Capillary Electrophoresis , 1989, Bio/Technology.

[12]  Reiner Westermeier,et al.  Electrophoresis In Practice , 1993 .

[13]  D. Ejima,et al.  Arginine as an effective additive in gel permeation chromatography. , 2005, Journal of chromatography. A.

[14]  C. Gibbs,et al.  The consistent use of organic solvents for purification of phospholipids from brain tissue effectively removes scrapie infectivity. , 1994, Biologicals (Print).

[15]  M. Havenga,et al.  Quantification of residual host cell DNA in adenoviral vectors produced on PER.C6 cells. , 2005, Human gene therapy.

[16]  C. Mant,et al.  Optimization of Peptide Separations in High-Performance Liquid Chromatography , 1989 .

[17]  J Luo,et al.  Antibody-antigen interactions measured by surface plasmon resonance: global fitting of numerical integration algorithms. , 2001, Journal of biochemistry.

[18]  Ulrich Kulozik,et al.  Quantitative assessment of thermal denaturation of bovine alpha-lactalbumin via low-intensity ultrasound, HPLC, and DSC. , 2006, Journal of agricultural and food chemistry.

[19]  C. Roitsch,et al.  6 – High-Performance Liquid Chromatography of Biologically Active Proteins in the Nanogram (Picomole) Range , 1985 .